Patents by Inventor Eric Fontaine

Eric Fontaine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mitochondrial activity inhibitors targeting tumoral metabolism
    Patent number: 12371402
    Abstract: The invention relates to compounds of formula (I) as follows: (I) wherein X1 and X2, identical or different, are NR5 or a sulfur atom, Y is a group (C1-C10)alkanediyl, Ar1 and Ar2, identical or different, are an aryl group optionally substituted by one or several groups selected from a halogen atom, a (C1-C6) alkyl, —OR1, —NR1R2 and —COOR3? with R1 and R2, independently of each other, are a hydrogen atom, a (C-1-C6) alkyl group or a —COR3 group, R3 and R4? independently of each other, are a hydrogen atom or a (C1-C6) alkyl group, and R5 is a hydrogen atom or a (C1-C6)alkyl group, or a pharmaceutically acceptable salt and/or solvate thereof, in particular for use in cancer treatment.
    Type: Grant
    Filed: November 28, 2019
    Date of Patent: July 29, 2025
    Assignees: CENTRE LEON BERARD, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE CLAUDE BERNARD LYON 1, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE GRENOBLE ALPES, UNIVERSITE DE CAEN NORMANDIE
    Inventors: Marc Billaud, Renaud Prudent, Martine Cordier-Bussat, Eric Fontaine, Patrick Dallemagne, Peggy Suzanne, Sylvain Rault
  • MITOCHONDRIAL ACTIVITY INHIBITORS TARGETING TUMORAL METABOLISM
    Publication number: 20220009884
    Abstract: The invention relates to compounds of formula (I) as follows: (I) wherein X1 and X2, identical or different, are NR5 or a sulfur atom, Y is a group (C1-C10)alkanediyl, Ar1 and Ar2, identical or different, are an aryl group optionally substituted by one or several groups selected from a halogen atom, a (C1-C6) alkyl, —OR1, —NR1R2 and —COOR3? with R1 and R2, independently of each other, are a hydrogen atom, a (C-1-C6) alkyl group or a —COR3 group, R3 and R4? independently of each other, are a hydrogen atom or a (C1-C6) alkyl group, and R5 is a hydrogen atom or a (C1-C6)alkyl group, or a pharmaceutically acceptable salt and/or solvate thereof, in particular for use in cancer treatment.
    Type: Application
    Filed: November 28, 2019
    Publication date: January 13, 2022
    Inventors: Marc BILLAUD, Renaud PRUDENT, Martine CORDIER-BUSSAT, Eric FONTAINE, Patrick DALLEMAGNE, Peggy SUZANNE, Sylvain RAULT
  • Rocking chair base
    Patent number: D559020
    Type: Grant
    Filed: February 20, 2007
    Date of Patent: January 8, 2008
    Assignee: Dutailier International Inc.
    Inventors: Charles Desnoyers, Eric Fontaine
  • Controller box dashboard
    Patent number: D828497
    Type: Grant
    Filed: February 7, 2017
    Date of Patent: September 11, 2018
    Assignee: LEONARD VALVE COMPANY
    Inventors: Ryan Foss, Eric Fontaine, Eric Costa, Richard Cota, Jr.